XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue        
Total revenue $ 967,205 $ 811,615 $ 1,436,950 $ 1,641,331
Operating expenses        
Cost of products sold 646,389 342,580 938,386 896,634
Cost of services 15,650 137,934 46,212 242,918
Research and development 2,273,756 2,859,590 4,590,197 5,673,081
General and administrative 2,134,266 2,692,255 4,759,319 5,355,912
Sales and marketing 1,169,349 802,549 2,220,781 1,701,801
Impairment of right-of-use asset 115,218 170,714
Total operating expenses 6,239,410 6,950,126 12,554,895 14,041,060
Operating loss (5,272,205) (6,138,511) (11,117,945) (12,399,729)
Other (expense) income        
Gain on extinguishment of debt 259,353 259,353
Warrant inducement expense (7,755,541)
Interest and other income 13,851 4,702 16,972 9,627
Interest expense (779,912) (1,198,169) (2,049,493) (2,363,151)
Foreign currency transaction gains (losses) 271,967 (915) 470,707 426,700
Change in fair value of derivative financial instruments (74,116) (13,021) 35,628 (114,411)
Total other expense (568,210) (948,050) (1,526,186) (9,537,423)
Loss before income taxes (5,840,415) (7,086,561) (12,644,131) (21,937,152)
Provision for income taxes
Net loss (5,840,415) (7,086,561) (12,644,131) (21,937,152)
Net loss available to common stockholders $ (5,840,415) $ (7,086,561) $ (12,644,131) $ (21,937,152)
Net loss per common share - basic and diluted (in Dollars per share) $ (0.13) $ (0.19) $ (0.27) $ (0.65)
Weighted average shares outstanding - basic and diluted (in Shares) 46,574,512 38,268,293 46,529,718 33,900,964
Net loss $ (5,840,415) $ (7,086,561) $ (12,644,131) $ (21,937,152)
Other comprehensive income (loss) - foreign currency translation (1,227,142) 529,651 (1,710,991) (548,828)
Comprehensive loss (7,067,557) (6,556,910) (14,355,122) (22,485,980)
Product sales        
Revenue        
Total revenue 889,271 307,804 1,255,323 835,383
Laboratory services        
Revenue        
Total revenue 20,570 266,784 63,499 450,849
Collaboration revenue        
Revenue        
Total revenue $ 57,364 $ 237,027 $ 118,128 $ 355,099